Woodford Investment Management (WIM) is to take a 15% performance fee of any excess returns above the 10% annual return target on its Patient Capital investment trust.
The trust will charge no annual management fee alongside this charge, a move the company said will align manager Neil Woodford's interests with shareholders. WIM said the performance fee will be subject to a high watermark, meaning it will not be able to charge the fee simply when making up previous underperformance. Ongoing annual expenses are not expected to exceed 0.35%, the group added. It said 80% of the performance fee will be payable in the trust's shares, with the remainder in cash to contribute toward any tax liability of the manager arising from the payment of the fee. ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes